Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction

NCT01466270 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

62

Enrollment

OTHER

Sponsor class

Conditions

Anxiety Disorder
Breast Cancer
Cognition Disorders
Depression
Fatigue
Sleep Disorders

Interventions

DRUG: donepezil hydrochloride
DRUG: Placebo

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]